Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.
Daniel Morales-CanoMaria CallejoBianca BarreiraGema Mondejar-ParreñoSergio Esquivel-RuizSonia RamosMaría Ángeles MartínAngel CogolludoLaura MorenoFrancisco Pérez VizcaínoPublished in: PloS one (2019)
Diabetes is a very strong predictor of chronic systemic vascular diseases and acute cardiovascular events. Recently, associations between metabolic disorders and pulmonary hypertension have also been reported in both humans and animal models. In order to get some further insight into the relationship of pulmonary hypertension with obesity, insulin resistance and hyperglycemia, herein we have used the Zucker diabetic fatty rats (ZDF/clr-lepr fa) at 20 weeks fed a standard diet and compared to their lean Zucker littermates (ZL). ZDF rats were obese, had elevated plasma glucose levels and insulin resistance, i.e. a clinically relevant model of type 2 diabetes. They presented elevated systolic, diastolic and mean pulmonary arterial pressures and a parallel increase in the Fulton index. Systemic arterial pressures were also increased but the left ventricle plus septum weight was similar in both groups and the heart rate was reduced. Wall media thickening was observed in the small pulmonary arteries from the ZDF rats. Isolated pulmonary arteries mounted in a wire myograph showed similar vasoconstrictor responses to phenylephrine and 5-HT and similar responses to the endothelium-dependent vasodilator acetylcholine. However, the iNOS inhibitor 1400W enhanced the vasoconstrictor responses in ZDF but not in ZL rats. The protein expression of eNOS and iNOS was not significantly different in the lungs of the two groups. The lung expression of Bmpr2 mRNA was downregulated. However, the mRNA expression of Kcna5, Kcnk3, Kcnq1, Kcnq4 or Kcnq5, which encode for the potassium channels Kv1.5, TASK-1, Kv7.1, Kv7.4 and Kv7.5, respectively, was similar in ZL and ZDF rats. In conclusion, ZDF rats show increased pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arterial medial thickening and downregulated lung Bmpr2 despite leptin resistance. These changes were mild but are consistent with the view that diabetes is a risk factor for pulmonary hypertension.
Keyphrases
- pulmonary hypertension
- pulmonary arterial hypertension
- pulmonary artery
- type diabetes
- insulin resistance
- heart rate
- blood pressure
- cardiovascular events
- weight loss
- metabolic syndrome
- adipose tissue
- cardiovascular disease
- coronary artery disease
- physical activity
- left ventricular
- high fat diet
- body mass index
- heart failure
- computed tomography
- magnetic resonance
- oxidative stress
- skeletal muscle
- hepatitis b virus
- heart rate variability
- image quality
- fatty acid
- liver failure
- high fat diet induced
- body composition
- bone mineral density
- preterm birth
- obese patients